These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3542853)

  • 1. Jogging causes a significant increase in platelet sensitivity to prostacyclin.
    Sinzinger H; Fitscha P
    Int J Sports Med; 1986 Dec; 7(6):338-41. PubMed ID: 3542853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
    Kristensen SD; Knudsen F; Nielsen AH; Ring T
    Clin Nephrol; 1984 Apr; 21(4):230-4. PubMed ID: 6375926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in some aspects of platelet function with improvement of glycaemic control over 6 months.
    Collier A; Tymkewycz PM; Matthews DM; Jones RL; Clarke BF
    Diabetes Res; 1987 Jun; 5(2):79-82. PubMed ID: 2443296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K; Löbel P; Steinhagen-Thiessen E
    Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
    Pedvis LG; Wong T; Frojmovic MM
    Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation during steady state sickle cell disease.
    Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
    J Med; 1983; 14(1):17-36. PubMed ID: 6224876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
    Milton JG; Frojmovic MM
    J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U; von Schenck H; Wallentin L
    Thromb Haemost; 1985 Dec; 54(4):808-12. PubMed ID: 3911481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N
    Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target.
    Gurbel PA; Antonino MJ; Bliden KP; Dichiara J; Suarez TA; Singla A; Tantry US
    Platelets; 2008 Dec; 19(8):595-604. PubMed ID: 19012177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of calcium antagonists on platelet function and vascular prostacyclin production.
    Pirich C; Schmid P; Fitscha P; Wytek R; O'Grady J; Sinzinger H
    Blood Press Suppl; 1994; 1():75-80. PubMed ID: 8205307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGI2 and PGE1 induce morphological alterations in human platelets similar to those of the initial phase of activation.
    Zilla P; Groscurth P; Varga G; Fischlein T; Fasol R
    Exp Hematol; 1987 Aug; 15(7):741-9. PubMed ID: 3301381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
    Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
    Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.